Acquired qnrVC1 and blaNDM-1 resistance markers in an international high-risk Pseudomonas aeruginosa ST773 clone.
Anti-Bacterial Agents
/ pharmacology
Ceftazidime
/ pharmacology
Ciprofloxacin
/ pharmacology
Drug Resistance, Multiple, Bacterial
/ genetics
Fluoroquinolones
/ pharmacology
Genome, Bacterial
Humans
Integrons
Microbial Sensitivity Tests
Mutation
Pseudomonas aeruginosa
/ drug effects
Whole Genome Sequencing
beta-Lactamases
/ genetics
NDM
Pseudomonas aeruginosa
multidrug resistance
qnrVC
Journal
Journal of medical microbiology
ISSN: 1473-5644
Titre abrégé: J Med Microbiol
Pays: England
ID NLM: 0224131
Informations de publication
Date de publication:
Mar 2019
Mar 2019
Historique:
pubmed:
23
1
2019
medline:
20
3
2019
entrez:
23
1
2019
Statut:
ppublish
Résumé
A multidrug-resistant Pseudomonas aeruginosa PS1 isolated from urine clinical sample was investigated in this study. The strain exhibited resistance to piperacillin/tazobactam, ciprofloxacin, imipenem, ceftazidime but it was susceptible to colistin. Analysis of whole-genome sequencing data by ResFinder detected various resistance determinants including qnrVC1 and blaNDM-1. The multiresistant P. aeruginosa isolate belonged to ST773 high-risk clone. The qnrVC1 and blaNDM-1 determinants were incorporated into different integrons. Expression of blaNDM-1 was fourfold and qnrVC1 was twofold increased, compared to that of rpsL housekeeping gene. Mutations in gyrA Thr83Leu and parC Ser87Leu were detected and additionally qnrVC1 expression indicates protective effect of QnrVC1 pentapeptid protein on gyrase and topoisomerase. High-risk P. aeruginosa clones integrate various carbapenemase and other resistance determinants into their genomes that facilitates further dissemination of multiresistance among clinical isolates. We report blaNDM-1 and qnrVC1 genes in P. aeruginosa ST773 international high-risk clone.
Identifiants
pubmed: 30667355
doi: 10.1099/jmm.0.000927
doi:
Substances chimiques
Anti-Bacterial Agents
0
Fluoroquinolones
0
Ciprofloxacin
5E8K9I0O4U
Ceftazidime
9M416Z9QNR
beta-Lactamases
EC 3.5.2.6
beta-lactamase NDM-1
EC 3.5.2.6
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM